应用不同血管活性药物阴茎海绵体注射排除血管性阳萎

APPLICATION OF INTRACAVENOUS INJECTION OF DIFFERENT VASCULAR DIALATION DRUGS FOR REMOVING VASCULOGENIC ERECTILE DYSFUNCTION

采用不同血管活性药物及不同剂量对670例阳萎患者进行阴望海绵体内注射以排除血管性阳萎。结果96.9％的非血管性阳萎患者在应用婴栗碱30mg加酚妥拉明1mg注射后可获充分勃起，2％在罂桑碱加至60mg时获充分勃起。而对罂染减注射反应不佳的非血管性阳萎患者行PGE25μg注射后有0．9％获充分勃起，PGE1加至50μg时又有0．2％获得勃起。应用罂粟碱的患者17．8％出现异常勃起，而应用PGEI的患者46．1％出现明茎疼痛。提示不应以某种单一剂量或药物注射来排除血管性阳萎，并宜从小剂量用起，减少共发症。

670 cases of erectile dysfunction (ED) underwent ICI to remove vasculogenic ED.96.4 % patients with non-vasculogenic got full erection after ICI of Fapaverine 3Omg plus regitine 1mg,and so did another 2 % after adding papaverine to 6omg. The other non-vasculogenic ED patients, not responding to papaverine, were given ICI of PGE,25μ, or 50μg if not respoded well to 25μg. Againthere were 0. 9% and 0. 2% patients who obtamed full erection respectively. Persistent erection curred in 7. 8% of patients with ICI of papaverine.while local pain occurred in 46. 1 % of patients with ICI of PGE1. These indicate that ICI of one dosage or one sort of drugs is not reliable in removing vasculaogenic ED, and in order to diminish complications, ICI should beain from small dosage.